Transcription activator-like effector nucleases (TALENs) and RNA-guided nucleases derived from clustered, regularly interspaced, short palindromic repeats (CRISPR)-Cas9 systems have become ubiquitous genome editing tools. Despite this, the impact that distinct high-order chromatin conformations have on these sequence-specific designer nucleases is, presently, ill-defined. The same applies to the relative performance of TALENs and CRISPR/Cas9 nucleases at isogenic target sequences subjected to different epigenetic modifications. Here, to address these gaps in our knowledge, we have implemented quantitative cellular systems based on genetic reporters in which the euchromatic and heterochromatic statuses of designer nuclease target sites are stringently controlled by small-molecule drug availability. By using these systems, we demonstrate that TALENs and CRISPR/Cas9 nucleases are both significantly affected by the high-order epigenetic context of their target sequences. In addition, this outcome could also be ascertained for S. pyogenes CRISPR/Cas9 complexes harbouring Cas9 variants whose DNA cleaving specificities are superior to that of the wild-type Cas9 protein. Thus, the herein investigated cellular models will serve as valuable functional readouts for screening and assessing the role of chromatin on designer nucleases based on different platforms or with different architectures or compositions.
INTRODUCTION
Transcription activator-like effector (TALE) nucleases (TALENs) and RNA-guided clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated Cas9 (CRISPR/Cas9) nucleases, have become the prevalent tools for inducing targeted double-stranded DNA breaks (DSBs) in living cells (1, 2) .
Native TALE proteins have evolved in phytopathogenic bacteria (Xanthomonas sp.) to serve as transcriptional activators of specific host plant genes whose products promote infection (1, 2) . Typically, TALE DNA-binding domains consist of an array of 15.5-19.5 repeats composed of 33-34 residues containing polymorphisms called repeat variable di-residues (RVDs) at positions 12 and 13. Individual RVDs mediate the binding of the repeat in which they are embedded to a particular nucleotide. This direct oneto-one interaction between nucleotides and repeats permits the straightforward assembling of artificial proteins, among which TALENs, with specific DNA binding activities. Indeed, TALENs are built by fusing the DNA-binding programmable polymorphic repeats from TALE proteins to the nuclease domain of the type IIS restriction enzyme FokI (1, 2) . The recognition of preselected genomic sequences by TALEN pairs leads to in situ FokI dimerization resulting in nuclease activation and targeted DSB formation.
Native CRISPR/Cas9 nucleases have evolved in bacteria and archaea as adaptive immune systems to fend off invading nucleic acids (e.g. bacteriophage and plasmid DNA) whose chromatin signatures are, clearly, fundamentally different from those present in and acquired by eukaryotic nuclear genes (3) . Programmable CRISPR/Cas9 nucleases are ribonucleoprotein complexes composed of a sequencetailored single guide RNA (gRNA) and a Cas9 protein harboring two nuclease domains (i.e. RuvC and HNH). The 5 and 3 ends of the gRNAs serve as targeting and scaffolding moieties for Cas9, respectively. The initial interaction between CRISPR/Cas9 complexes and DNA involves binding of Cas9 to a nucleotide sequence named protospacer adjacent motif (PAM; NGG in the case of the prototypic Cas9 from S. pyogenes). This initial engagement with DNA is mediated through a composite PAM-interacting domain located in two regions of the Cas9 protein (4) . Subsequently, targeted DSB formation is triggered after the hybridization of the 5 end of the gRNA to a complementary ∼20-bp genomic target sequence located next to the PAM (1, 2) . Therefore, TALENs and CRISPR/Cas9 nucleases operate in strikingly different manners in that the target site specificity of the former is governed via protein-DNA interactions, whilst that of the latter is ultimately dictated by RNA-DNA hybridizations (1, 2) . The activation of cellular DNA repair pathways resulting from the activity of these sequence-specific designer nucleases is being harnessed in an ever-increasing number of genome editing settings. For instance, the repair of targeted DSBs via non-homologous end joining (NHEJ) can result in the incorporation of small insertions and deletions (indels) leading to gene knock-out or gene correction (1, 2) .
Well-defined parameters that can affect targeted DSB formation by TALENs and CRISPR/Cas9 nucleases in cellula include their specific construction, composition, primary target sequence and, in the case of TALENs, CpG methylation (5, 6) . In contrast, there has been no direct and quantitative assessment of the impact that high-order chromatin conformations have on these gene-editing tools at isogenic target sites (7) . By the same token, an investigation of the relative performance of TALENs and CRISPR/Cas9 nucleases at target sequences subjected to different epigenetic modifications is equally lacking. Indeed, hitherto, studies based mostly on catalytically 'dead' Cas9 enzymes have exclusively correlated preferential interactions of CRISPR/Cas9 complexes with open chromatin regions bearing candidate off-target sites (e.g. 5-nucleotide seed sequences followed by the S. pyogenes's PAM) (7) (8) (9) (10) (11) . In this regard, it is also of note that binding of CRISPR/Cas9 complexes to DNA is, for the most part, uncoupled from actual phosphodiester bond cleavage (7, 8, 11) . Here, to cover these gaps in our knowledge, we have adapted and validated cellular systems for tracking and measuring the impact of the epigenetically regulated three-dimensional chromatin structure on gene editing processes. By using these reporter systems, we demonstrate that TALENs and CRISPR/Cas9 nucleases are both significantly hindered by the chromatin context in which their target sequences are embedded.
MATERIALS AND METHODS

Recombinant DNA
The lentiviral transfer plasmid AD12 pLV.TetO.TLR.TetO (Supplementary Figure S1 ) was constructed by inserting tTR-KRAB binding elements upstream and downstream of the TLR construction (12) in pCVL Traffic Light Reporter 1.1 (Sce target) Ef1a Puro (Addgene plasmid #31482, herein referred to as pLV.TLR) by using standard recombinant DNA techniques. The lentiviral transfer plasmid pLVCT-tTR-KRAB (13) used to assemble LVCT-tTR-KRAB vector particles for the generation of reporter cells HEK.EGFP TetO.KRAB , was obtained from Addgene (#11643). Likewise for the TALEN expression plasmids TAL2050 (#39408), TAL2051 (#39409),  TAL2072 (#39442), TAL2073 (#39443), TAL2076  (#39446), TAL2077 (#39447), TAL2094 (#39428) and  TAL2095 (#39429) encoding, respectively, TALEN-26-L,  TALEN-26-R, TALEN-43-L, TALEN-43-R, TALEN-45-L, TALEN-45-R, TALEN-36-L and TALEN-36-R proteins based on the Xanthomonas axonopodis pv. citri TALE scaffold (14) . The TALEN expression plasmids  AR36 pTALEN-GA-L and AR37 pTALEN-GA-R code  for, respectively, TALEN-L  EGFP and TALEN-R  EGFP (15);  herein referred to as TALEN-GA-L and TALEN-GA-R,  respectively. The TALEN-GA-L and TALEN-GA-R proteins are based on the Xanthomonas campestris pv. armoraciae TALE scaffold and were custom-designed by GeneArt Gene Synthesis (ThermoFisher Scientific). The expression plasmid hCas9 (16) ; herein referred to as pCMV.Cas9, contains a human codon-optimized ORF coding for the Streptococcus pyogenes Cas9 nuclease (Addgene plasmid #41815). The gRNA acceptor plasmid S7 pUC.U6.sgRNA.Bvel-stuffer has a U6 RNA Pol III promoter for driving gRNA expression and was constructed as follows. The construct pLKO.1-puro.U6.sgRNA.BfuAI.stuffer (17) (Addgene plasmid #50920) was treated with BclI and, subsequently, with the Klenow fragment (both from ThermoFisher Scientific). Next, this vector backbone was dephosphorylated with FastAP (ThermoFisher Scientific) and ligated to a Klenow fragment-blunted 3431-bp DMD cDNA fragment harboring four BveI sites. This fragment was isolated after digesting pDysE (18) with EcoRI (ThermoFisher Scientific). Of note, the presence of extra BveI sites aids in achieving complete BveI digestion of the respective gRNA acceptor plasmid. These manoeuvres yielded AA19 pLKO.1-puro.U6.sgRNA.BveI-stuffer (Supplementary Figure S2) . Finally, after digesting AA19 pLKO.1-puro.U6.sgRNA.BveI-stuffer with BveI (ThermoFisher Scientific) and EcoRI, the resulting 3822-bp insert was ligated to a 2676-bp fragment obtained by treating cloning vector pUCBM21 (Boehringer Mannheim) with HincII (ThermoFisher Scientific) and EcoRI. This cloning step led to the generation of gRNA acceptor plasmid S7 pUC.U6.sgRNA.Bvelstuffer (Supplementary Figure S3) . The expression plasmids coding for gRNA TLR , gRNA GFP2 , gRNA GFP3 , gRNA GFP4 , gRNA GFP5 , gRNA GFP6 and gRNA GFP7 were assembled by inserting annealed oligonucleotide pairs
5 -ACCGTAGGTCAGGGTGGTCAC GA-3 / 5 -AAACTCGTGACCACCCTGACCTA-3 an d 5 -ACCGGCGAGGGCGATGCCACCTA-3 / 5 -AAA CTAGGTGGCATCGCCCTCGC-3 into BveI-digested S7 pUC.U6.sgRNA.Bvel-stuffer, respectively.
The EGFP target sequences for gRNA GFP4 , gRNA GFP5 , gRNA GFP6 were described previously as NGG site 1, NGG site 2 and NGG site 3, respectively (19) . The target sequence for gRNA GFP7 was also described before (20) . The construct gRNA GFP T2 (17) Figure S4 ) was first digested with NotI and HincII, to remove the hrGFP ORF, after which the 5019-bp backbone fragment was extracted from the agarose gel. Next, the backbone was blunted and dephosphorylated by using the Klenow Fragment of the E. coli DNA polymerase I and FastAP, respectively (both from Thermo Fisher Scientific). The constructs VP12 (Addgene plasmid #72247) (19) and eSpCas9(1.1) (Addgene plasmid #71814) (21) encode the high-specificity Cas9 variants SpCas9-HF1 and eSpCas9(1.1), respectively. The ORFs coding for wild-type Cas9, SpCas9-HF1 and eSpCas9(1.1) were isolated from agarose gel after double digesting pCMV.Cas9 (16), VP12 and eSpCas9(1.1) with XbaI/MssI, NotI/MssI and AseI/EcoRI, respectively. The insert fragments corresponding to Cas9, SpCas9-HF1 and eSpCas9(1.1) were then blunted and ligated to the aforementioned plasmid backbone yielding expression plasmids AV62 pCAG.Cas9.rBGpA, AV64 pCAG.SpCas9-HF1.rBGpA and AW01 pCAG.eSpCas9(1.1).rBGpA, respectively.
Cells
HEK293T cells (American Type Culture Collection) and HEK293T cell-derived clone HEK.EGFP TetO.KRAB were cultured as indicated elsewhere (22) . HER.TLR TetO.KRAB cells and their control TetO-negative counterparts HER.TLR KRAB cells were maintained in DMEM supplemented with 10% fetal bovine serum (FBS), 10 mM MgCl 2 and hygromycin B (ThermoFisher Scientific) at a final concentration of 45 g/ml. These cells were stably transfected with a tTR-KRAB expression plasmid based on the pcDNA3.1/Hygro(+) backbone (Life Technologies). The various cell types were kept at 37
• C in a humidified-air 10% CO 2 atmosphere.
Lentiviral vectors
The generation of lentiviral vectors LVCT-tTR-KRAB, LV.TetO.TLR.TetO and LV.TLR was done by transfecting, respectively, pLVCT-tTR-KRAB, pLV.TetO.TLR.TetO and pLV.TLR into HEK293T cells together with packaging construct psPAX2 (Addgene #12260) and pseudotyping plasmid pLP/VSVG (Life Technologies), essentially as described in detail elsewhere (23, 24) .
Experimental models
The single cell-derived clone HEK.EGFP TetO.KRAB , harboring a tTR-KRAB-regulated EGFP allele, was generated by transducing HEK293T cells with LVCT-tTR-KRAB.
In brief, 5 × 10 4 cells were seeded in wells of 24-well plates (Greiner Bio-One). After 24 h, the cells were exposed to 1, 0.5, 0.25, 0.125 and 0.062 Hela cell-transducing units (HTU)/cell of LVCT-tTR-KRAB. At 48 h posttransduction, the cells exposed to each vector multiplicity of infection (MOI) were split into wells of 6-well plates (Greiner Bio-One). At 6 days after transduction, these cells were either kept in regular culture medium or in culture medium supplemented with 500 ng/ml doxycycline (Dox). Three days later EGFP-directed flow cytometry analysis was carried out. The cell culture transduced with an MOI of 0.125 HTU/cell contained 6.9% and 0.34% of EGFP-positive cells in the presence and absence of Dox, respectively. This cell culture was selected for isolating LVCT-tTR-KRAB-transduced clones by adding 200 l of a cell suspension with a concentration of 1.5 cells/ml into wells of 96-well plates (Greiner Bio-One). To increase the cloning efficiency, the culture medium was supplemented with 50 M of ␣-thioglycerol and 20 nM of bathocuprione disulphonate (both from SigmaAldrich) (25) LV.TLR transduced cells were exposed to hygromycin and puromycin. After 2 weeks in selection medium, puromycinresistant polyclonal cell populations were expanded for carrying out transfection experiments and, where indicated, kept in the presence of Dox (500 ng/ml).
DNA transfections
Transfections were started by mixing each of the relevant plasmids and 1 mg/ml polyethyleneimine (PEI, Polysciences) in 50 l of a 150 mM NaCl solution (Supplementary Tables S1-S4 ). These transfections were done in cells cultured in the absence or in the presence of Dox. In addition, for determining gene delivery efficiencies, all transfection mixtures contained a reporter-encoding plasmid. After around 10 s of vigorous vortexing, the DNA-PEI complexes were incubated at room temperature for 15 min and were subsequently directly applied into the medium of the target cells that had been seeded one day before. After 6-8 h, the transfection mixtures were removed and fresh reg- 
Chromatin immunoprecipitation (ChIP) and qPCR
The HER.TLR TetO.KRAB cells were cultured in the presence or in the absence of Dox (500 ng/ml) for 11 days, after which a cell fixation protocol available at https://www. activemotif.com, was applied. In brief, 2 ml of a freshly prepared formaldehyde solution was added into the cell culture medium. The culture flasks were subsequently agitated for exactly 15 min at room temperature. Next, 1.1 ml of 2.5 M glycine was applied to stop the fixation process. After a 5-min incubation period at room temperature, the cells were scraped and transferred to a 50-ml tube. The collected cells were subjected to two cycles of centrifugation at 800 ×g for 10 min. After the first cycle, the cells were resuspended in 10 ml of pre-chilled Igepal solution (0.05% Igepal in phosphate buffered saline (PBS)), whilst after the second cycle a 10 ml 0.05% Igepal solution mixed with 100 l phenylmethanesulfonyl fluoride (Sigma P-7626, 100 mM in ethanol), was used instead. A final centrifugation at 800 ×g for 10 min was carried out to harvest the fixed cell pellets. Subsequently, the ChIP-qPCR assays were performed on 30 g of cross-linked chromatin according to the HistonePath TM ChIP-qPCR protocol (Active Motif). The ChIP-validated antibodies H3 pan-acetyl (Active Motif, cat # 39139) and H3K9me3 (Active Motif, cat # 39161) were used for the ChIP. Next, qPCR amplifications with primer pairs (Supplementary Table S5 ) targeting six different TLR TetO regions (i.e. SFFV promoter, EF1α promoter, puromycin resistance gene, mCherry sequence, 5 and 3 EGFP gene segments) were performed. Additional primer pairs were used for the quality control of the ChIP-qPCR assays (Supplementary Table S5 ).
The qPCR amplifications were performed with the aid of a Bio-Rad CFX Connect Real-time detection system running the CFX Manager TM software. The qPCR amplifications were carried out in triplicate for each sample and primer pair. The qPCR mixtures consisted of 12.5 ng of input DNA, 1x iQ SYBR Green Supermix (Bio-Rad) and 250 nM of each primer in a total volume of 20 l. The qPCR program started with a 2-min incubation period at 95
• C. This was followed by 40 cycles consisting of 15 s at 95
• C, 20 s at 58
• C and 20 s at 72
• C. Next, the samples were sequentially incubated at 95
• C and 55
• C for 1 min. The melting curves were derived by increasing the temperature from 55
• C to 95
• C with a rate of 0.5
• C for every 10 s. The binding events detected per 1000 cells were calculated based on chromatin input amounts, final ChIP volumes and primer efficiencies. Finally, the data were normalized using the algorithm available at https://www.activemotif.com.
Statistical analysis
The comparison of data sets resulting from a minimum of three independent experiments were analyzed by using the GraphPad Prism 6 software package and monitored for significance by applying two-tailed Student's t-tests with P < 0.05 considered significant. The data sets derived from two independent experiments done in biological replicate in HER.TLR KRAB were analyzed by using the IBM SPSS Statistics 23 software package and monitored for significance by employing a three-way ANOVA test with P < 0.05 considered significant. One-way ANOVA combined with Bonferroni tests were used for the statistical analysis of the data corresponding to the screening of the high-specificity Cas9 variants. P < 0.05 was considered significant. The IBM SPSS Statistics 23 software package was used in this analysis. 
RESULTS AND DISCUSSION
To investigate and compare the impact that the chromatin structure has on the performance of TALENs and CRISPR-Cas9 complexes, we have set-up two complementary quantitative cellular systems dubbed HER.TLR TetO.KRAB and HEK.EGFP TetO.KRAB . In these systems, the chromatin conformations (i.e. euchromatic versus heterochromatic) at isogenic target sequences are stringently controlled through small-molecule drug availability. In particular, these experimental models based on human cells, harbor reporter alleles whose transition from compact to relaxed chromatin is governed through doxycycline (Dox)-dependent release of a dominantly silencing tTR-KRAB fusion protein from its cognate TetO recognition elements ( Figure 1A) . The Krüppel-associated box domain (KRAB) is the effector moiety of the largest class of transcriptional repressors in vertebrates. The binding of KRAB-containing proteins to DNA triggers epigenetic silencing mechanisms involving the recruitment of, amongst others, scaffolding and chromatin remodeling factors such as KRAB-associated protein 1 (KAP-1) and heterochromatin protein 1 (HP-1) (27, 28) . The impinged facultative heterochromatin is characterized by epigenetic marks of silenced genes (29, 30) .
The first system, HER.TLR TetO.KRAB , consists of tTR-KRAB-expressing human embryonic retinoblasts containing a Traffic Light Reporter (TLR) construct (12), which we have herein modified by flanking it with TetO (TLR TetO ) elements ( Figure 1B) . The original TLR construct has an out-of-frame mCherry reporter located downstream of a T2A sequence and an EGFP ORF disrupted by an I-SceI recognition site (12) . The repair by NHEJ of DSBs made at sequences upstream of mCherry generates indels that can place the nucleotide sequence of mCherry in-frame. The resulting red fluorescent cells thus report sequence-specific nuclease activity. To validate the cellular model based on the adapted TLR construct TLR TetO , ChIP-qPCR assays were performed on HER.TLR TetO.KRAB cells incubated in the presence or in the absence of Dox. In these assays, antibodies directed against histone 3 acetylation (H3Ac) and histone 3 lysin 9 trimethylation (H3K9me3), characteristic of open and closed chromatin, respectively, were used. The ChIP-qPCR analysis established a Dox-dependent switch of TLR TetO sequences from a heterochromatic to a euchromatic state ( Figure 1C) . Indeed, in HER.TLR TetO.KRAB cells not exposed to Dox, the enrichment factors for the heterochromatin mark H3K9me3 at six randomly-selected ChIP-qPCR target regions spanning the TLR TetO gene body varied from a minimum of 2.2-fold to a maximum of 14.4-fold when compared to those measured in their Doxtreated counterparts ( Figure 1C, left panel) . Conversely, in HER.TLR TetO.KRAB cells exposed to Dox, the enrichment factors for the euchromatin mark H3Ac at the same ChIP-qPCR target regions ranged from a minimum of 1.1-fold to a maximum of 61.7-fold when compared to those measured in their Dox-negative counterparts ( Figure 1C , right panel). These variations in histone modifications are well within those reported to induce biologically relevant changes in cells (30, 31) . Taken together, these data validate the TLR TetO construction as a Dox-dependent epigenetically controlled system that can be used for studying the effect of chromatin conformation on the performance of gene editing tools. The second system, HEK.EGFP TetO.KRAB , entails tTR-KRAB-expressing human embryonic kidney cells with a TetO-flanked functional EGFP allele (12) ( Figure  1D ). In this system, the traceable cellular phenotype consists of non-fluorescent cells emerging from the incorporation of frame-shifting indels at EGFP sequences after NHEJ-mediated DSB repair. In conclusion, the generation of DSBs within isogenic euchromatic and heterochromatic target sites located in TLR and EGFP reporter genes can readily be tracked in cellula by quantifying mCherrypositive and EGFP-negative cells, respectively ( Figure 1E) .
We started by transfecting HER.TLR TetO.KRAB and HEK.EGFP TetO.KRAB cells, cultured in the presence or in the absence of Dox, with expression plasmids encoding TALENs and CRISPR/Cas9 nucleases (Supplementary Figure S5) . Parallel cell cultures transfected with constructs expressing a single TALEN monomer, Cas9 plus a nontargeting gRNA or Cas9 plus an 'empty' gRNA, served as negative controls (Ctrl). After the action of the various designer nucleases had taken place, all cell cultures were exposed to Dox in order to allow for transgene activation and ensuing flow cytometric analysis ( Figures 1E and 2) . The resulting data revealed that in HER.TLR TetO.KRAB and HEK.EGFP TetO.KRAB cells (i.e. ORF correction and ORF disruption readouts, respectively), the frequencies of DSB formation were significantly lower in cells whose target sites were embedded in heterochromatin (-Dox) when compared to those attained when the same sites were located in euchromatin (+Dox) instead ( Figure 3A -D and Supplementary Figure S6 ). Indeed, euchromatic target sequences in reporter HER.TLR TetO.KRAB and HEK.EGFP TetO.KRAB cells were cleaved by CRISPR/Cas9 complexes on average 2.7-and 2.2-fold, more frequently than when they were in a heterochromatic state ( Figure 3A and B, respectively) . Similarly, euchromatic target sites in reporter HER.TLR TetO.KRAB and HEK.EGFP TetO.KRAB cells were cut by TALEN dimers on average 5.2-and 3.0-fold more often than their isogenic heterochromatic counterparts ( Figure 3C and D, respectively). Thus, these ratios between the levels of targeted DSB formation in epigenetically open versus closed DNA can be One-way ANOVA compared the experimental groups with a subsequent comparison between groups being done by Bonferroni analysis (P < 0.05 was considered significant). referred to as the chromatin impact index of a particular nuclease.
Of note, the TALEN pairs TALEN-43-L/TALEN-43-R and TALEN-GA-L/TALEN-GA-R ( Figure 3C and D, respectively) are based on different architectures consisting of TALE scaffolds from Xanthomonas axonopodis pv. citri and Xanthomonas campestris pv. armoraciae, respectively (32, 33) . Importantly, no differences in designer nuclease-induced targeted DSB frequencies were measured in HER.TLR KRAB cells whose TLR sequences are not subjected to conditional KRAB-mediated epigenetic regulation ( Figure 3E cells differ from each other in that the former lacks the cis-acting TetO elements ( Figures 1A and 3E , respectively). In particular, expression of TALEN dimers and CRISPR/Cas9 complexes directed to TLR sequences in HER.TLR KRAB cells led to similar levels of site-specific DSB formation in Dox-containing and Dox-free settings resulting in chromatin impact indexes of roughly 1 for both types of designer nucleases ( Figure 3F and G) .
Next, we carried out another series of gene knockout experiments in HEK.EGFP TetO.KRAB cells by using a panel of TALENs composed of different numbers of TALE repeats in their DNA-binding arrays. Once again, the frequencies of targeted gene knockout were highest in cells containing euchromatic target sites ( Figure 4A and B) . Interestingly, the TALEN complex built on monomers with the shortest TALE DNA-binding domains was the most hindered by having its target sequence embedded in heterochromatin. In fact, under this condition, this TALEN pair led to gene editing levels barely above background (Figure 4A ). These data suggest that a minimum TALEN DNAbinding energy is necessary in order to overcome the compact heterochromatic barrier and induce meaningful levels of site-specific DSB formation. Nonetheless, it is important to point out that the majority of TALEN proteins currently in use contain DNA-binding domains made up of well over 14.5 TALE repeats (i.e. typically, 17.5 to 18.5 TALE repeats per monomer) (1, 2) .
Informed by structural data (4,34), two independent research groups have recently generated S. pyogenes Cas9 variants with targeting DNA specificities markedly superior to that of their parental wild-type counterpart (19, 21) . These high-specificity variants, dubbed SpCas9-HF1 (19) and eSpCas9(1.1) (21), have amino acid substitutions which reduce nonspecific protein-DNA interactions and, as a result, constrain the respective ribonucleoprotein complexes to preferentially cut at the intended target sites. The SpCas9-HF1 mutations N497A, R661A, Q695A and Q926A reduce protein binding to the sugar-phosphate backbone of the complementary strand by removing hy-drogen bridges; the charged-to-alanine eSpCas9(1.1) mutations K848A, K1003A and R1060A affect protein binding to the non-complementary stand by eliminating cationic amino acids along the nt-groove located between the HNH and RuvC-like nuclease domains. Regardless of their different point mutations and modus operandi, these engineered Cas9 variants contribute to addressing in a very direct manner a major issue in the genome-editing field, that is, the need for reducing off-target DNA cleaving activities as these can confound experimental outcomes and obstruct potential clinical applications. To determine the relative chromatin impact indexes of these new Cas9 variants, we carried out targeted gene knockout experiments in HEK.EGFP TetO.KRAB cells. In these experiments, constructs encoding wild-type Cas9, SpCas9-HF1 or eSpCas9(1.1) were transfected together with plasmids expressing five different EGFP-targeting gRNAs. Data presented in Figure  5A show that, as previously established for wild-type Cas9, high-specificity Cas9 variants were both hindered by heterochromatin. Interestingly, of the two variants, the SpCas9-HF1 protein was the most affected in these experiments as indicated by its higher chromatin impact index ( Figure 5B ).
Taken together, our data establishes that distinct highorder epigenetically regulated chromatin conformations can have a significant impact on DNA cleaving activity regardless of the type of the designer nuclease tested and of the specific nucleotide sequence targeted. Moreover, of the two main designer nuclease platforms currently in use, TALENs seem to be the most influenced by the high-order chromatin status of their target DNA as revealed by the cumulative data presented in Figure 6 . In this regard, it is interesting noting that although the RNA-guided system has not evolved to assess and cleave chromosomal DNA in eukaryotic cell nuclei, it can nonetheless perform relatively well in human cells when compared to TALENs (Figure 6) . However, regardless of the nuclease platform ultimately chosen, chromatin impact indexes of two or higher ( Figure 6 ) are relevant for the ultimate performance of genome editing protocols in different experimental settings, including those aiming at bi-allelic or multi-allelic target gene knockouts. Our results complement recent biochemical data demonstrating that nucleosome occupancy obstructs CRISPR/Cas9-mediated DNA cleavage (35) . Interestingly, comparison of targeted DSB formation by TALENs and CRISPR/Cas9 nucleases at different CCR5 sequences in induced pluripotent stem cells did not show a correlation between indel frequencies and the distribution of DNaseI hypersensitive sites retrieved from the ENCODE database (36) . Whether this finding is specific to the DNaseI hypersensitive site profile selected or to the experimental design used, would need further investigation.
In the present work, we have presented and validated two complementary functional readouts for investigating and comparing in a quantitative manner the role of highorder chromatin structures on genome editing events resulting from the use of sequence-specific designer nucleases. By using these quantitative assays, we have demonstrated that TALENs and CRISPR/Cas9 nucleases are both significantly hindered by closed chromatin in living cells. We conclude that, in addition to the well-established parameters mentioned earlier, the chromatin conformation constitutes yet another determinant of the ultimate efficiencies resulting from using TALENs and CRISPR/Cas9 nucleases. The approaches described in our work should be directly applicable for screening and selecting specific designer nuclease reagents from different platforms or with different architectures and compositions (e.g. hybrid nucleases, engineered homing endonucleases, Cas9 orthologues, novel Cas9 variants and gene editing tools co-opted from new DNA-targeting systems). In addition, they should also be valuable for assessing the impact of chromatin on different gene editing strategies, including those based on paired 'nickases', truncated guide RNAs and homology-directed gene repair.
